All In Biotech

Free tool

FAERS Monitor: Hycamtin

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 020671 or its brand name (Hycamtin, Topotecan Hydrochloride). Reports on generic versions are filed under their own applications.

Reports

6,942

Serious

6,366

92% of reports

Hospitalization

2,628

Death reported

1,654

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • febrile neutropenia603
  • anaemia580
  • off label use575
  • death573
  • neutropenia559
  • nausea477
  • disease progression457
  • thrombocytopenia453
  • pyrexia449
  • vomiting437
  • product use in unapproved indication377
  • fatigue337
  • white blood cell count decreased326
  • diarrhoea324
  • malignant neoplasm progression321

Reports by year received

View as table
YearReports
2004138
2005216
2006123
2007185
2008159
2009201
2010238
2011259
2012313
2013231
2014301
2015394
2016397
2017347
2018408
2019340
2020473
2021490
2022430
2023355
2024344
2025396
2026203

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,047,217 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
febrile neutropeniaSignal60327.825.715,451
neutropeniaSignal55912.511.55,919
thrombocytopeniaSignal45312.311.34,706
disease progressionSignal45711.710.74,489
malignant neoplasm progressionSignal3219.58.62,445
anaemiaSignal5809.28.54,279
white blood cell count decreasedSignal3269.18.22,359
product use in unapproved indicationSignal3774.64.21,075
pyrexiaSignal4493.93.6995
vomitingSignal4372.82.6522
deathSignal5732.01.9305
off label use5752.01.8294
nausea4771.81.7184
diarrhoea3241.51.459
fatigue3371.31.226

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.